Daljit Singh Aurora, See Remarks at Neumora Therapeutics, Inc. (NMRA), sold 229,406 shares at $2.68 ($615K) on 2025-11-11, disclosed to the SEC on 2025-11-13.
Scheduled sale ($615k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.68 | 114,703 | $307K | 50.0% |
| 2 | $2.68 | 114,703 | $307K | 50.0% |
| Total | $2.68 avg | 229,406 | $615K | 100% |
| Filing → |
| NMRA | SELL | 2026-02-19 | $22K | — | Filing → |
| NMRA | SELL | 2025-02-20 | $14K | — | Filing → |